| 中國醫藥大學 |
2004 |
P53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer
|
Wu, HC; Chang, CH; Chen, HY; Tsai, FJ; Tsai, JJP; Chen, WC |
| 中國醫藥大學 |
2004 |
P53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer
|
Wu, HC; Chang, CH; Chen, HY; Tsai, FJ; Tsai, JJP; Chen, WC |
| 中國醫藥大學 |
2004-02 |
p53 gene codon 72 polymorphism but not tumor necrosis factor-α gene is associated with prostate cancer.
|
吳錫金(Wu,Hsi-Chin); (Chao-Hsiang Chang); 陳慧毅(Huey-Yi Chen); 蔡輔仁(Fuu-Jen Tsai); (Jeffery J.P. Tsai)*; 陳汶吉(Chen Wen-Chi) |
| 中國醫藥大學 |
2006-03 |
P53 gene codon 72 prolin/arginine polymorphism in hashimoto's thyroiditis
|
陳榮興(Rong-Hsing Chen); 張淳堆(Chwen-Tzuei Chang); 陳汶吉(Wen-Chi Chen); 蔡輔仁(Fuu-Jen Tsai) |
| 中原大學 |
1996 |
p53 gene mutation in cerebral primitive neuroectodermal tumor in Taiwan
|
Yat-Sen Ho;Ling-Ling Hsieh;Jen-Shi Chen;Chen-Nen Chang;Shih-Tseng Lee;Li-Ling Chiu;Ting-Yu Chin;Su-Chu Cheng |
| 中原大學 |
1996-05-15 |
p53 gene mutation in thyroid carcinoma
|
Yat-Sen Ho;Su-Chu Tseng;Ting-Yu Chin;Ling-Ling Hsieh;Jen-Der Lin |
| 國立成功大學 |
2005-01-18 |
P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium
|
Tsai, Yi-Yu; Cheng, Ya-Wen; Lee, Huei; Tsai, Fuu-Jen; Tseng, Sung-Huei; Chang, Kong-Chao |
| 中國醫藥大學 |
2005 |
P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium
|
Tsai, YY; Cheng, YW; Lee, H; Tsai, FJ; Tseng, SH; Chang, KC |
| 中國醫藥大學 |
2005 |
P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium
|
Tsai, YY; Cheng, YW; Lee, H; Tsai, FJ; Tseng, SH; Chang, KC |
| 國立臺灣大學 |
1995 |
P53 Gene Mutational Spectra in Hepatocellular Carcinomas Induced by 2- Acetyaminofluorene and N-Nitroso-2-Acetylaminofuorene in Rats
|
Ho, Y. S.; Chen, H. T.; Wang, J. Y.; 林仁混; Ho, Y. S.; Chen, H. T.; Wang, J. Y.; Lin, Jen-Kun |
| 國立臺灣大學 |
1995 |
P53 Gene Mutational Spectra in Hepatocellular Carcinomas Induced by 2- Acetylaminofluorene and N-Nitroso-2-Acetyl-Aminofluorene in Rats
|
Ho, Yuan-Soon; Cheng, Hui-Teng; Wang, Ying-Jan; 林仁混; Ho, Yuan-Soon; Cheng, Hui-Teng; Wang, Ying-Jan; Lin, Jen-Kun |
| 臺大學術典藏 |
2021-03-15T08:47:01Z |
p53 gene mutational spectra in hepatocellular carcinomas induced by 2-acetylaminofluorene and N-nitroso-2-acetylaminofluorene in rats
|
Yuan-Soon Ho; HUI-TENG CHENG; Ying-Jan Wang; Jen-Kun Lin |
| 臺大學術典藏 |
2021-03-15T08:26:23Z |
p53 gene mutational spectra in hepatocellular carcinomas induced by 2?acetylaminofluorene and N?nitroso?2?acetylaminofluorene in rats
|
Ho Y.?S.; HUI-TENG CHENG; Wang Y.?J.; Lin J.?K. |
| 臺大學術典藏 |
2021-03-15T08:44:22Z |
p53 gene mutational spectra in hepatocellular carcinomas induced by 2?acetylaminofluorene and N?nitroso?2?acetylaminofluorene in rats
|
Ho Y.?S.; HUI-TENG CHENG; Wang Y.?J.; Lin J.?K. |
| 國立臺灣大學 |
1994 |
P53 Gene Mutations in Brain Tumors in Taiwan
|
謝玲玲; Hsia, C. F.; Wang, L. Y.; 陳建仁; Ho, Y. S.; Hsieh, Ling-Ling; Hsia, C. F.; Wang, L. Y.; Chen, Chien-Jen; Ho, Y. S. |
| 臺大學術典藏 |
2018-09-10T05:13:17Z |
p53 gene mutations in primary lung cancer
|
LI-NA LEE; LI-NA LEE |
| 臺大學術典藏 |
2019-04-26T07:13:17Z |
P53 ICE CRIM mouse: a tool to generate mutant allelic series in somatic cells and germ lines for cancer studies
|
Fan, Hsiang-Hsuan;Yu, I-Shing;Lin, Yin-Hung;Wang, Shin-Yu;Liaw, Ying-Hsuan;Pei-Lung Chen;Tsung-Lin Yang;Shu-Wha Lin;You-Tzung Chen; Fan, Hsiang-Hsuan; Yu, I-Shing; Lin, Yin-Hung; Wang, Shin-Yu; Liaw, Ying-Hsuan; PEI-LUNG CHEN; TSUNG-LIN YANG; SHU-WHA LIN; You-Tzung Chen |
| 臺大學術典藏 |
2020-11-04T01:59:18Z |
P53 ICE CRIM mouse: A tool to generate mutant allelic series in somatic cells and germ lines for cancer studies
|
YOU-TZUNG CHEN; Lin S.-W.; Yang T.-L.; Chen P.-L.; Liaw Y.-H.; Wang S.-Y.; Fan H.-H.; Shing Yu I.; Lin Y.-H. |
| 臺大學術典藏 |
2021-07-06T02:03:56Z |
P53 ICE CRIM mouse: A tool to generate mutant allelic series in somatic cells and germ lines for cancer studies
|
Fan H.-H.;Shing Yu I.;Lin Y.-H.;Wang S.-Y.;Liaw Y.-H.;Pei-Lung Chen;Yang T.-L.;Lin S.-W.;Chen Y.-T.; Fan H.-H.; Shing Yu I.; Lin Y.-H.; Wang S.-Y.; Liaw Y.-H.; PEI-LUNG CHEN; Yang T.-L.; Lin S.-W.; Chen Y.-T. |
| 國家衛生研究院 |
2024-05 |
p53 inhibitor or antioxidants reduce the severity of ethmoid plate deformities in zebrafish type 3 treacher collins syndrome model
|
Ulhaq, ZS;You, MS;Jiang, YJ;Tse, WKF |
| 亞洲大學 |
2014-06 |
p53 Is a Key Regulator for Osthole-Triggered
|
蔡政芳;Tsai, Cheng-Fang |
| 亞洲大學 |
2014-06 |
p53 Is a Key Regulator for Osthole-Triggered Cancer Pathogenesis
|
Hua, Ssu-Ming;Huang, Ssu-Ming;蔡政芳;Tsai, Cheng-Fang;Chen, Dar-Ren;Chen, Dar-Ren;Wan, Min-Ying;Wang, Min-Ying;Yeh, Wei-Lan;Yeh, Wei-Lan |
| 國家衛生研究院 |
2018-12 |
p53 is sequestered by mitochondrial chaperone Lon in the matrix to restrain apoptosis under oxidative stress
|
Sung, YJ;Lee, YL |
| 國立成功大學 |
2013-02-15 |
p53 modulates the AMPK inhibitor compound C induced apoptosis in human skin cancer cells
|
Huang, Shi-Wei; Wu, Chun-Ying; Wang, Yen-Ting; Kao, Jun-Kai; Lin, Chi-Chen; Chang, Chia-Che; Mu, Szu-Wei; Chen, Yu-Yu; Chiu, Husan-Wen; Chang, Chuan-Hsun; Liang, Shu-Mei; Chen, Yi-Ju; Huang, Jau-Ling; Shieh, Jeng-Jer |
| 國立臺灣大學 |
1998 |
P53 Mutation in Advanced Stage of Primary Myelodysplastic Syndrome
|
唐季祿; 田蕙芬; 陳耀昌; TANG, JIH-LUH; TIEN, HWEI-FANG; CHEN, YAO-CHANG |
| 臺大學術典藏 |
2021-07-03T03:36:01Z |
P53 mutation in advanced stage of primary myelodysplastic syndrome
|
Tang J.-L.; Tien H.-F.; Lin M.-T.; PEI-JER CHEN; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-06T03:59:03Z |
P53 mutation in advanced stage of primary myelodysplastic syndrome
|
JIH-LUH TANG; Tien H.-F.; Lin M.-T.; Chen P.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2021-05-26T09:08:25Z |
P53 mutation in advanced stage of primary myelodysplastic syndrome
|
Tang J.-L.; Tien H.-F.; Lin M.-T.; Chen P.-J.; YAO-CHANG CHEN |
| 臺大學術典藏 |
2021-01-04T12:13:08Z |
P53 mutation in advanced stage of primary myelodysplastic syndrome
|
HWEI-FANG TIEN; Lin M.-T.; Tang J.-L.; Chen P.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2018-09-10T06:12:56Z |
p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan
|
Lunn, R.M. and Zhang, Y.-J. and Wang, L.-Y. and Chen, C.-J. and Lee, P.-H. and Lee, C.-S. and Tsai, W.-Y. and Santella, R.M.; PO-HUANG LEE |
| 臺大學術典藏 |
2020-11-19T03:43:22Z |
p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan
|
Lunn R.M.; Zhang Y.-J.; Wang L.-Y.; Chen C.-J.; PO-HUANG LEE; Lee C.-S.; Tsai W.-Y.; Santella R.M.; Lunn R.M.;Zhang Y.-J.;Wang L.-Y.;Chen C.-J.;Po-Huang Lee;Lee C.-S.;Tsai W.-Y.;Santella R.M. |
| 國立暨南國際大學 |
2012 |
p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation
|
余長澤; Yu, CTR |
| 國立臺北護理健康大學 |
1993-11 |
p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade and stage in bladder cancer
|
Esrig, D;Spruck, CH;Nichols, PW;Chaiwun, B;Steven, K;Groshen, S;Chen, S-C;Skinner, DG;Jones, PA;Cote, RJ |
| 國立臺灣大學 |
2004 |
P53 Overexpression and Mutation in Metaplastic Carcinoma of the Breast: Genetic Evidence for a Monoclonal Origin of Both the Carcinomatous and the Heterogeneous Sarcomatous Components
|
連晃駿; 林中梧; 毛翠蓮; 郭頌鑫; 蕭正祥; 黃俊升; LIEN, HUANG-CHUN; LIN, CHUNG-WU; MAO, TSUI-LIEN; KUO, SUNG-HSIN; HSIAO, CHENG-HSIANG; HUANG, CHIUN-SHENG |
| 國立臺灣大學 |
2004-10 |
p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien, HC; Lin, CW; Mao, TL; Kuo, SH; Hsiao, CH; Huang, CS: |
| 臺大學術典藏 |
2018-09-10T04:46:16Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien, H.-C. and Lin, C.-W. and Mao, T.-L. and Kuo, S.-H. and Hsiao, C.-H. and Huang, C.-S.; CHIUN-SHENG HUANG; Sung-Hsin Kuo; CHUNG-WU LIN; HUANG-CHUN LIEN |
| 臺大學術典藏 |
2020-03-03T03:36:54Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Chung-Wu Lin;Mao T.-L.;Kuo S.-H.;Hsiao C.-H.;Huang C.-S.; Lien H.-C.; CHUNG-WU LIN; Mao T.-L.; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2020-03-05T05:51:25Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Huang-Chun Lien;Lin C.-W.;Mao T.-L.;Kuo S.-H.;Hsiao C.-H.;Huang C.-S.; HUANG-CHUN LIEN; Lin C.-W.; Mao T.-L.; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2020-03-07T06:48:26Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Lin C.-W.;Tsui-Lien Mao;Kuo S.-H.;Hsiao C.-H.;Huang C.-S.; Lien H.-C.; Lin C.-W.; TSUI-LIEN MAO; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2020-03-23T07:19:35Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Lin C.-W.;Mao T.-L.;Kuo S.-H.;Hsiao C.-H.;Chiun-Sheng Huang; Lien H.-C.; Lin C.-W.; Mao T.-L.; Kuo S.-H.; Hsiao C.-H.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2020-03-05T12:32:57Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.; Lin C.-W.; TSUI-LIEN MAO; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2021-02-23T08:26:44Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Lin C.-W.;Mao T.-L.;Sung-Hsin Kuo;Hsiao C.-H.;Huang C.-S.; Lien H.-C.; Lin C.-W.; Mao T.-L.; SUNG-HSIN KUO; Hsiao C.-H.; Huang C.-S. |
| 國立臺灣大學 |
2002 |
P53 Overexpression Predicts Poor Chemosensitivity to High-Dose 5- Fluorouracil Plus Leucovorin Chemotherapy for Stage Iv Colorectal Cancers after Palliative Bowel Resection
|
梁金銅; 黃國晉; 鄭永銘; 許輝吉; 鄭安理; 徐志宏; 葉坤輝; 王世名; 張金堅; LIANG, JIN-TUNG; HUANG, KUO-CHIN; JENG, YUNG-MING; HSU, HEY-CHI; CHENG, ANN-LII; HSU, CHIH-HUNG; YEH, KUN-HUEI; WANG, SHIH-MING; CHANG, KING-JEN |
| 臺大學術典藏 |
2020-04-28T07:25:39Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.;Huang K.-C.;Cheng Y.-M.;Hsu H.-C.;Cheng A.-L.;Chih-Hung Hsu;Yeh K.-H.;Wang S.-M.;Chang K.-J.; Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; CHIH-HUNG HSU; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-01-28T01:06:53Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.;Huang K.-C.;Cheng Y.-M.;Hsu H.-C.;Cheng A.-L.;Hsu C.-H.;Kun-Huei Yeh;Wang S.-M.;Chang K.-J.; Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-01-14T03:09:20Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.; KUO-CHIN HUANG; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-05-03T02:21:22Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
JIN-TUNG LIANG; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-09-01T02:02:28Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2022-08-12T06:28:26Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; KING-JEN CHANG |
| 高雄醫學大學 |
2011 |
p53 peptide prevents LITAF-induced TNF-alpha-mediated mouse lung lesions and endotoxic shock.
|
Tang, X;O'Reilly, A;Asano, M;Merrill, JC;橫山一成;Amar, S. ; Tang, X;O'Reilly, A;Asano, M;Merrill, JC;Yokoyama, KK;Amar, S. |
